Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00049179
Status:
COMPLETED
Last Update Posted:
2015-03-06
First Post:
2002-11-12
Brief Title:
S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Sponsor:
SWOG Cancer Research Network
Organization:
SWOG Cancer Research Network
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
Keywords:
| Name | View |
|---|---|
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute monocytic leukemia M5b | View |
| adult acute erythroid leukemia M6 | View |
| adult acute megakaryoblastic leukemia M7 | View |
| adult acute myeloblastic leukemia with maturation M2 | View |
| adult acute myeloblastic leukemia without maturation M1 | View |
| adult acute myelomonocytic leukemia M4 | View |
| adult acute monoblastic leukemia M5a | View |
| recurrent adult acute myeloid leukemia | View |
| secondary acute myeloid leukemia | View |
| adult acute myeloid leukemia with t821q22q22 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |
| adult acute myeloid leukemia with inv16p13q22 | View |